Long COVID and Related Infection-Associated Chronic Illnesses

Oct 11–14, 2027 | Fairmont Hotel Vancouver, Vancouver, BC, Canada
Scientific Organizers: Michael J Peluso, Carmen Scheibenbogen, E. John Wherry, and Letícia Soares

  Livestream
  In Person
  On Demand
×

-

Oct 11–14, 2027 | Fairmont Hotel Vancouver, Vancouver, BC, Canada

Scientific Organizers: Michael J Peluso, Carmen Scheibenbogen, E. John Wherry, and Letícia Soares

Supported by:  

***Meeting program subject to change.

Available Formats:     = Livestream   = In Person     = On Demand
Monday, October 11, 2027
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Tuesday, October 12, 2027
Breakfast
7:00–8:00 AM
Keynote Address
8:00–9:00 AM
Eric Topol †, The Scripps Research Institute
Pathogens as a Cause of Chronic Illness and the Implications for Human Health
Immune Dysregulation, Autoimmunity, and Host Susceptibility
9:00–11:15 AM
Carmen Scheibenbogen, Charite University
Autoimmunity as a Driver of ME/CFS
Nadia R Roan †, University of California, San Francisco
Immunobiology of Sex Differences in Long COVID
Jessica Lasky-Su †, Harvard Medical School
What RECOVER-Omics Is Teaching Us About Long COVID
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Panel Discussion 1: Clinical Heterogeneity Across Populations and Conditions
11:25–12:25 PM
Poster Setup
12:25–1:00 PM
On Own for Lunch
12:25–2:30 PM
Poster Viewing
1:00–10:00 PM
Symposia Spotlight 1: Emerging Findings from Clinical Trials
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Tissue and Neuroimmune Biology of Infection-Associated Chronic Illness
5:00–7:00 PM
Akiko Iwasaki †, Yale University/HHMI
The Neuroimmune Axis in Infection-Associated Chronic Illness
Marcus Buggert †, Karolinska Institutet
Tissue-Based Immunologic Endotyping in Long COVID
Michelle James †, Stanford University
Imaging the Biology of Long COVID and ME/CFS
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Wednesday, October 13, 2027
Breakfast
7:00–8:00 AM
Persistent and Reactivated Pathogens Across Chronic Disease
8:00–11:00 AM
James Stone †, Massachusetts General Hospital
Mapping SARS-CoV-2 Persistence Through the RECOVER Autopsy Program
Christian Münz †, University of Zurich
EBV Immune Control in Infection-Associated Chronic Disease
Allen Eghrari †, Johns Hopkins School of Medicine Faculty
Pathogen Persistence and Immune Dysfunction Following Ebola Virus Disease
Monica Embers †, Tulane University
Borrelia Persistence in Lyme Disease
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Diverse and Emerging Mechanisms of Infection-Associated Chronic Illness
5:00–7:00 PM
Rob Wust †, Vrije University Amsterdam
Skeletal Muscle Dysfunction and Post-Exertional Malaise in Long COVID
Lael Yonker †, UT Southwestern Medical Center
Gut Barrier Dysfunction, Viral Antigen, and Microbial Translocation in Adults and Children with Long COVID
E. John Wherry, University of Pennsylvania
Immune Signatures of Persistent Microbes
Katerina Akassoglou †, Icahn School of Medicine at Mount Sinai
Spike-Fibrin Interactions in Thromboinflammation and Neuropathology After COVID-19
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Thursday, October 14, 2027
On Own for Lunch
12:10–5:00 PM
Breakfast
7:00–8:00 AM
Challenges and Opportunities in Infection-Associated Chronic Illness Research
8:00–11:00 AM
Michael J Peluso, University of California, San Francisco
The Challenge of Biomarker Development in Long COVID and Lessons from the UCSF VIPER Program
Leonard H Calabrese †, Cleveland Clinic
The Neurobiology of Placebo and Nocebo Effects in Chronic Illness
Letícia Soares, Patient-Led Research Collaborative
What Patients Say We Should Measure in Long COVID Clinical Trials
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Panel Discussion 2: Building a Diagnostic and Therapeutic Development Ecosystem
11:10–12:10 PM
Symposia Spotlight 2: New Tools for Diagnosis, Stratification, and Mechanistic Discovery
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
What Clinical Trials Can Teach Us About Disease Biology
5:00–6:45 PM
Peter Marks †, Eli Lilly
Developing Drugs for a Disease Without Clear Diagnostic Markers
Birgit Sawitzki †, Berlin Institute of Health at Charité
What NKSG Trials Reveal About Long COVID and ME/CFS Biology
Øystein Fluge †, Haukeland University Hospital / University of Bergen
Targeting B Cells and Plasma Cells to Probe ME/CFS Pathogenesis
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions
6:45–7:00 PM
Social Hour with Dinner
7:00–8:00 PM
Entertainment
8:00–11:00 PM
Cash Bar
8:00–11:00 PM
Friday, October 15, 2027
Departure
12:00–11:59 PM

Subscribe for Updates